Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsIndia

Supreme Court refuses to stay Central Vista redevelopment project

The Rs 20,000 crore project aims to build a new triangular parliament building, 10 new buildings to accommodate government offices and new residences for the Prime Minister and the Vice-President.

April 30, 2020 / 04:47 PM IST

The Supreme Court on April 30 refused to stay the ambitious Central Vista project. The apex court was hearing a plea that questioned the lavish Rs 20,000 crore spend when the government was struggling to build cash reserves to fight the pandemic and revive the economy.

The Rs 20,000 crore project aims to build a new triangular parliament building, 10 new buildings to accommodate government offices and new residences for the Prime Minister and the Vice-President.

Track this blog for LIVE updates on the COVID-19 pandemic 

The petitioner claimed urgency, arguing before the apex court that the government had already begun seeking clearances from various authorities to begin the redevelopment project.

The petitioner had argued that at a time when the government was indulging in austerity measures such as the halting of dearness allowance (DA) payments to government employees, the use of Rs 20,000 crore for the Central Vista Project was not advisable. The petitioner had sought for rerouting funds to help fight the pandemic and revive the economy.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The court, however, was not impressed. It observed that during the lockdown, it was highly unlikely that any serious redevelopment work could be initiated.

Meanwhile, Solicitor General Tushar Mehta, appearing for the government, rebutted the claims of the petitioners by arguing that the project was aimed at, among other things, to build a new parliament.

Before the Supreme Court, the SG asked, "Why should anyone have an objection (to the construction of a new parliament)?"

Interestingly, in a similar matter, on March 6, the SC had passed an interim order, directing that any steps taken by the authorities, shall be subject to the outcome of the proceedings in SC.

Source: CNBC-TV18 
CNBC-TV18
first published: Apr 30, 2020 04:44 pm

stay updated

Get Daily News on your Browser
Sections